Vivus Inc. (VVUS)’s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years
Insane that 17% of the float was short, GG.
Vivus Weight-Loss Pill Wins FDA Panel Backing - Bloomberg